Muscle atrophy and preferential loss of myosin in prolonged critically ill patients*
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Muscle weakness contributes to prolonged rehabilitation and adverse outcome of critically ill patients. Distinction between a neurogenic and/or myogenic underlying problem is difficult using routine diagnostic tools. Preferential loss of myosin has been suggested to point to a myogenic component. We evaluated markers of muscle atrophy and denervation, and the myosin/actin ratio in limb and abdominal wall skeletal muscle of prolonged critically ill patients and matched controls in relation to insulin therapy and known risk factors for intensive care unit-acquired weakness. DESIGN: Secondary analysis of two large, prospective, single-center randomized clinical studies. SETTING: University hospital surgical and medical intensive care unit. PATIENTS: Critically ill patients and matched controls. INTERVENTIONS: Intensive care unit patients had been randomized to blood glucose control to 80-110 mg/dL with insulin infusion or conventional glucose management, where insulin was only administered when glucose levels rose above 215 mg/dL. MEASUREMENTS AND MAIN RESULTS: As compared with controls, rectus abdominis and vastus lateralis muscle of critically ill patients showed smaller myofiber size, decreased mRNA levels for myofibrillar proteins, increased proteolytic enzyme activities, and a lower myosin/actin ratio, virtually irrespective of insulin therapy. Increased forkhead box O1 action may have played a role. Most alterations were more severe in patients treated with corticosteroids. Duration of corticosteroid treatment, independent of duration of intensive care unit stay or other risk factors, was a dominant risk factor for a low myosin/actin ratio. The immature acetylcholine receptor subunit γ messenger RNA expression was elevated in vastus lateralis, independent of the myosin/actin ratio. CONCLUSIONS: Both limb and abdominal wall skeletal muscles of prolonged critically ill patients showed downregulation of protein synthesis at the gene expression level as well as increased proteolysis. This affected myosin to a greater extent than actin, resulting in a decreased myosin/actin ratio. Muscle atrophy was not ameliorated by intensive insulin therapy, but possibly aggravated by corticosteroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Self-citationIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 5×
“The ICU patients had been included in two large, prospective, randomized controlled studies on strict blood glucose control with intensive insulin therapy in a surgical (16) and medical (17) ICU (Supplemental Fig.”
BackgroundMethodInfluentialSelf-citationSandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012 · cited 2×
“FoxO transcription factors are central players in muscle wasting (37, 38).”
BackgroundOne-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
Herridge, M. S., Cheung, A. M., Tansey, C. M., Matte-Martyn, A., Diaz-Granados, N., Al-Saidi, F., Cooper, A. B., Guest, C. B., Mazer, C. D., Mehta, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022450 · Cited by 2,334 · cited 1×
“Several observational studies have shown corticosteroids to be a risk factor of ICU-acquired paresis (2, 51, 52), whereas others found no effect of corticosteroids (1, 3, 53).”
BackgroundHermans, G., Wilmer, A., Meersseman, W., Milants, I., Wouters, P. J., Bobbaers, H., Bruyninckx, F., & Van den Berghe, G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-665oc · Cited by 368 · cited 7×
“sharp waves or fibrillation potentials (23, 24).”
BackgroundMethodInfluentialSelf-citationInsufficient Activation of Autophagy Allows Cellular Damage to Accumulate in Critically Ill Patients
Vanhorebeek, I., Gunst, J., Derde, S., Derese, I., Boussemaere, M., Güiza, F., Martinet, W., Timmermans, J.-P., D'Hoore, A., Wouters, P. J., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2563 · Cited by 241 · cited 2×
“03 Control 5 (45) 6 (55) 4 (100) 0 (0) CIT 17 (24) 55 (76) 9 (32) 19 (68) IIT 7 (14) 43 (86) 11 (39) 17 (61) .”
BackgroundSelf-citation
Cited by
ICU-Acquired Weakness and Recovery from Critical Illness
Kress, J. P., & Hall, J. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1209390 · Cited by 855
Clinical review: intensive care unit acquired weakness
Hermans, G., & Van den Berghe, G. (2015) · Critical Care · doi:10.1186/s13054-015-0993-7 · Cited by 792
“Several processes during critical illness may promote such wasting of muscle protein, which preferentially involves myosin [25, 26].”
BackgroundSelf-citationVanhorebeek, I., Latronico, N., & Van den Berghe, G. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05944-4 · Cited by 717
Self-citationPhysical Complications in Acute Lung Injury Survivors: A Two-Year Longitudinal Prospective Study
Fan, E., Dowdy, D. W., Colantuoni, E., Mendez-Tellez, P. A., Sevransky, J. E., Shanholtz, C., Dennison Himmelfarb, C. R., Desai, S. V., Ciesla, N., Herridge, M. S., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000040 · Cited by 615
“Immobility and enforced bed rest are modifiable risk factors during critical illness that can result in substantial disuse atrophy and accelerated muscle breakdown (17, 24, 53), contributing to the development of ICUAW (25, 54).”
BackgroundThe Sick and the Weak: Neuropathies/Myopathies in the Critically Ill
Friedrich, O., Reid, M. B., Van den Berghe, G., Vanhorebeek, I., Hermans, G., Rich, M. M., & Larsson, L. (2015) · Physiological Reviews · doi:10.1152/physrev.00028.2014 · Cited by 396
Self-citationThe impact of extended bed rest on the musculoskeletal system in the critical care environment
Parry, S. M., & Puthucheary, Z. A. (2015) · Extreme Physiology & Medicine · doi:10.1186/s13728-015-0036-7 · Cited by 383
“Recent human studies have demonstrated a reduction in muscle myofibre size with preferential proteolysis of the thick myosin filaments [91, 92] with one trial demonstrating a dramatic increase in protein degradation of up to 160 % [92].”
BackgroundHermans, G., Casaer, M. P., Clerckx, B., Güiza, F., Vanhullebusch, T., Derde, S., Meersseman, P., Derese, I., Mesotten, D., Wouters, P. J., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70183-8 · Cited by 364
Self-citationdos Santos, C., Hussain, S. N. A., Mathur, S., Picard, M., Herridge, M., Correa, J., Bain, A., Guo, Y., Advani, A., Advani, S. L., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2344oc · Cited by 282
The ICM research agenda on intensive care unit-acquired weakness
Latronico, N., Herridge, M., Hopkins, R. O., Angus, D., Hart, N., Hermans, G., Iwashyna, T., Arabi, Y., Citerio, G., Wesley Ely, E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4757-5 · Cited by 256
Self-citationMuscular weakness and muscle wasting in the critically ill
Schefold, J. C., Wollersheim, T., Grunow, J. J., Luedi, M. M., Z'Graggen, W. J., & Weber‐Carstens, S. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12620 · Cited by 193
Wollersheim, T., Woehlecke, J., Krebs, M., Hamati, J., Lodka, D., Luther-Schroeder, A., Langhans, C., Haas, K., Radtke, T., Kleber, C., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3224-9 · Cited by 143
“Our data are supported by other findings showing decreased protein synthesis in the skeletal muscle of critically ill patients [24].”
BackgroundResultHDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy
Beharry, A. W., Sandesara, P. B., Roberts, B. M., Ferreira, L. F., Senf, S. M., & Judge, A. R. (2014) · Journal of Cell Science · doi:10.1242/jcs.136390 · Cited by 128
“There are several potential mechanisms that might contribute to contractile dysfunction during muscle disuse, including (but not limited to) shifts in myosin isoforms (Caiozzo et al., 1998; Caiozzo et al., 1996; Campione et al., 1993; Fitts et al., 2000), alterations in Ca2+ release and sensitivity (Fraysse et al., 20…”
BackgroundInfluentialParry, S. M., Berney, S., Koopman, R., Bryant, A., El-Ansary, D., Puthucheary, Z., Hart, N., Warrillow, S., & Denehy, L. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001891 · Cited by 50
Metadata
- Authors
- Derde, S., Hermans, G., Derese, I., Güiza, F., Hedström, Y., Wouters, P. J., Bruyninckx, F., DʼHoore, A., Larsson, L., Van den Berghe, G., & Vanhorebeek, I.
- Venue
- Critical Care Medicine
- Published
- 2012-01
- Volume
- 40
- Issue
- 1
- Pages
- 79-89
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2036329632
- Cited by
- 157
- References
- 6
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.